Handbook of Clinical medicine

frequency in most patients; consider after risks and benefi ts discussion. 1st line: Propranolol 40–120mg/12h or topiramate 25–50mg/12h (teratogenic, can in- terfere with Pill effi cacy). Amitriptyline 10–75mg nocte can be used, though this is off -licence. Patients may be on previously-recommended prophylactic agents (eg valproate, pizotifen, pregabalin or ACE-i): if achieving good control then continue as required. 12-weekly botulinum toxin type A injections are a last resort in chronic migraine . Treatment during an attack: NICE recommends an oral triptan (or nasal in 12–17y) combined with either an NSAID or paracetamol.1 Monotherapy with any of the above (or aspirin 900mg) can also be considered. Anti-emetics may help even in the abscence of nausea and vomiting. Triptans are CI if IHD, coronary spasm, uncon- trolled  BP, recent lithium, SSRIS, or ergot use. Rare SE: arrhythmias or angina ± MI, even if no pre-existing risk. Non-pharmacological therapies: Warm or cold packs to the head, or rebreathing into paper bag (PaCO2) may help abort attacks. Butterbur extracts or ribofl avin supplementation may have a role. NICE recommend 10 sessions of acupuncture over 5–8 weeks if both topiramate and propranolol are unsuitable or ineff ective. Transcutaneous nerve stimulation may help. Considerations in
